Curran Simpson
CIK 1346164 · Chief Executive Officer · last filed 2026-01-08
Curran Simpson is a Chief Executive Officer who has filed 62 SEC Form 4 insider transactions across 2 companies since 2007. The most recent filing, for RGNX, was dated Jan 8, 2026. Across all open-market trades the lifetime net is −$25.8M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $2.3M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$2.28M
2
62
-$25.77M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| RGNX | Chief Executive Officer | 342,467 | $6.66 | $2.28M | -$17.42M | 38 | 2026-01-08 |
| HUMAN GENOME SCIENCES INC (HGSI) Delisted | Sr. VP, Operations | 0 | — | — | -$8.35M | 24 | 2012-08-01 |
Recent Filings
62 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-01-08 | RGNX | Grant (A) | +144,864 | $0 | EDGAR |
| 2026-01-06 | RGNX | Tax (F) | −18,559 | -$267.2K | EDGAR |
| 2025-10-10 | RGNX | Sell (S) | −20,811 | -$262.6K | EDGAR |
| 2025-10-01 | RGNX | Sell (S) | −7,624 | -$76.5K | EDGAR |
| 2025-09-12 | RGNX | Sell (S) | −7,734 | -$77.5K | EDGAR |
| 2025-07-03 | RGNX | Tax (F) | −4,701 | -$38.7K | EDGAR |
| 2025-01-14 | RGNX | Grant (A) | — | $0 | EDGAR |
| 2025-01-06 | RGNX | Mixed | +86,995 | -$92.1K | EDGAR |
| 2024-08-05 | RGNX | Sell (S) | −100 | -$1.5K | EDGAR |
| 2024-07-30 | RGNX | Sell (S) | −9,648 | -$145.1K | EDGAR |